Health Technology Assessment in South Africa: Towards NHI

By João L. Carapinha

June 4, 2024

Introduction

There are plans to implement Health Technology Assessment in South Africa on a wide scale. This will make sure that all HTA processes are standardized with the aim of using them for prioritizing areas where funds need to be allocated thus achieving fairness and effectiveness at the same time under National Health Insurance system. Although there have been some initiatives already carrying out HTAs, they lack continuity. By establishing a Ministerial Advisory Committee for HTA, the country hopes that creation of an independent and strong entity will assist on advising decision makers in the health sector.

The Development of Health Technology Assessment in South Africa

HTA has evolved in South Africa mainly through selection of Essential Medicines for the NEML (National Essential Medicine List). The latter guides procurement within public institutions and public health programs rely heavily on it. However different bodies perform HTA functions leading to duplication hence inefficiency. The NEML Committee historically concentrated much on evaluating drugs without adequate resources allocated towards this end. Additional efforts are also needed to strengthen the evidence-based approach to broadened the scope to include various medical devices and procedures.

Health Technology Assessment in South Africa
Source: Institutionalizing Health Technology Assessment in South Africa—An Opportunity in National Health Insurance.

The Significance of HTA under NHI

According to the NHI design, there should be a framework for HTA which starts at ministerial level before expanding into a national entity. This new body shall use scientific methods when assessing different healthcare interventions so that resources can be fairly distributed among them. The passing into law of the NHI Bill in 2024 marks significant progress. The post approval phase will involve HTAs being used to define a cost effective benefit package as well as shaping strategic purchasing decisions. It is also planned that this model should start off small but expand over time to ensure it’s sustainable implementation.

Strategies for Effective Implementation

For HTA to become a fixed part of the way things are done, current systems must be utilized. The first step is to create the Ministerial Advisory Committee and establish HTA policy frameworks. Secondly, contracting and involving stakeholders will be used to strengthen national HTA resources in the medium term. In the long run, the NHI should operationalize HTA processes to a level where they may become an independent body. This will mean investment in human resource capacity building, governance structures as well collaborative relationships with academic institutions.

Conclusion

Using HTA systematically under the NHI could lead to more efficient investment in healthcare. Clear methods for decision-making should be used when resource allocation decisions are involved. The successful incorporation of HTA into the NHI framework will depend on strong leadership, stakeholder collaboration, and ongoing commitment to capacity building. Ensuring equitable access to quality healthcare for all South Africans will ultimately validate the efforts to institutionalize HTA.

Reference url

Recent Posts

EU Life Sciences Strategy
         

EU Life Sciences Strategy: Paving the Way for Europe’s Leadership by 2030

🚀 Is Europe poised to reclaim its leadership in life sciences by 2030?

The European Commission has unveiled a game-changing strategy aimed at transforming the EU into the world’s leading hub for life sciences, tackling critical challenges in health, biotechnology, and sustainability. With strategic investments and reforms, this initiative promises to bridge the innovation gap and enhance public health outcomes across the continent.

Curious about how these plans will impact the life sciences landscape? Explore the full insights of this exciting strategy!

#SyenzaNews #HealthcareInnovation #DigitalTransformation #Innovation

ticagrelor data integrity
          

Ticagrelor Data Integrity Under Fire: Scrutiny Reveals Flaws in Key Clinical Trials

🔍 Are we truly getting the full story on high-cost medications like ticagrelor?

A recent BMJ investigation has raised alarm bells over the integrity of data from pivotal studies on AstraZeneca’s ticagrelor, revealing significant misreporting and missing data that may undermine its clinical benefits. This exposes critical implications for health economics, regulatory oversight, and market access.

Curious about how these findings could reshape perceptions of drug efficacy and safety? Dive into the full article to uncover the truth behind the numbers.

#SyenzaNews #HealthEconomics #Pharmaceuticals #MarketAccess

self-care public health
    

The Value of Self-Care in Public Health: Insights and Implications for Europe

🌍 Are we overlooking the power of self-care in Europe’s public health strategy?

The rise of self-care public health is reshaping how minor ailments are managed across the continent, leading to remarkable economic and productivity benefits. With annual savings of €36 billion and lifestyle improvements for consumers, self-care is proving to be a game-changer for healthcare systems.

Explore how embracing self-care can alleviate pressure on healthcare providers and enhance individual well-being. Dive into the full article to discover the implications for health economics and public policy!

#SyenzaNews #HealthEconomics #HealthcarePolicy

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2025 Syenza™. All rights reserved.